Frable William J
Department of Pathology, Virginia Commonwealth University, Medical College of Virginia, Richmond, VA, USA.
Arch Pathol Lab Med. 2006 May;130(5):620-5. doi: 10.5858/2006-130-620-SPRIRA.
A variety of methodologies have been used to report error rates in surgical pathology within the peer-reviewed medical literature. The media has selectively and superficially reported these error rates creating a climate of disinformation between physicians and the public.
To review the medical literature on diagnostic error in surgical pathology and summarize and compare these data with selected reports in the print and broadcast media.
A search of the medical literature from the National Library of Medicine database using the heading "Error and Pathology Diagnosis."
Three thousand nine hundred ninety-two citations were found, of which 83 directly measured in some manner errors in surgical and cytopathology. Major error rates ranged from 1.5% to 5.7% globally for institutional consults. Error rates were less, 0.26% to 1.2% for global in-house prospective review and 4.0% for in-house and retrospective blinded review. Error rates also varied by anatomic site: skin, institutional consult, 1.4%; prostate, institutional consult, 0.5%; and thyroid, institutional consult, 7.0%. Error rates reported in citations used by the Wall Street Journal were as follows: prostate, Gleason score changed by 1 point, 44% and resultant change in treatment for prostate cancer, 10%; for breast, altered lumpectomy or mastectomy plan, 8%; and diagnosis changed for thyroid lesions, 18%. Errors in second opinion on breast lesions (single pathologist author for the study) fall within the range of global reviews. Errors for second opinions on prostate cancer were principally 81% upgrades in Gleason score for prostate core needle biopsies. However, this resulted in an upgrade of patient risk category in only 10.8% of patients. Data for the article on change in diagnosis of thyroid lesions were incomplete. There appeared to be 3 significant diagnostic errors (4.5%).
Pathology is not immune to the power of the media to create concern about accuracy of diagnosis in surgical pathology and cytopathology. Detailed analysis of the medical literature cited by the media determines that painting the big picture and hitting the highlights can be profoundly misleading.
在同行评审的医学文献中,已采用多种方法来报告外科病理学中的错误率。媒体有选择性地、表面地报道了这些错误率,在医生和公众之间营造了一种虚假信息的氛围。
回顾关于外科病理学诊断错误的医学文献,并将这些数据与印刷媒体和广播媒体中的选定报道进行总结和比较。
使用标题“错误与病理学诊断”在国立医学图书馆数据库中检索医学文献。
共找到3992条引用文献,其中83条以某种方式直接测量了外科病理学和细胞病理学中的错误。全球机构会诊的主要错误率在1.5%至5.7%之间。全球内部前瞻性审查的错误率较低,为0.26%至1.2%,内部和回顾性盲法审查的错误率为4.0%。错误率也因解剖部位而异:皮肤,机构会诊,1.4%;前列腺,机构会诊,0.5%;甲状腺,机构会诊,7.0%。《华尔街日报》引用的文献中报道的错误率如下:前列腺,Gleason评分改变1分,44%,前列腺癌治疗方案随之改变,10%;乳腺癌,改变乳房肿块切除术或乳房切除术计划,8%;甲状腺病变诊断改变,18%。乳腺病变二次诊断的错误(该研究的单一病理学家作者)在全球审查范围内。前列腺癌二次诊断的错误主要是前列腺穿刺活检的Gleason评分81%升高。然而,这仅导致10.8%的患者风险类别升级。关于甲状腺病变诊断改变的文章数据不完整。似乎有3例重大诊断错误(4.5%)。
病理学无法免受媒体力量的影响,媒体会引发对外科病理学和细胞病理学诊断准确性的担忧。对媒体引用的医学文献进行详细分析后发现,勾勒大致情况并突出重点可能会产生严重误导。